Managing & Aligning Lists of Chemicals of High Concern

Similar documents
Hypodermic Needles Market Analysis, Size, Share, Growth, Industry Trends and Forecasts to Hexa Research

Dear Valued Customer,

Patrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference

Global Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )

THE VALUE OF A BD INTEGRATED SYSTEM FOR COMBINATION PRODUCTS

Quality Management System Certification. Understanding Quality Management System (QMS) certification

Public-Private Partnerships: Limelight on Diabetes. Renuka Gadde VP, Global Health October 18, 2012

DIABETES - FACT SHEET

AN INTRODUCTION TO YPSODOSE FOR THE LARGE-VOLUME INJECTION OF BIOLOGICS

Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595

For personal use only. Investor Briefing. Bayswater, 1 st December 2016

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage

ENVIRONMENTAL, HEALTH AND SAFETY LEGISLATION IN EUROPE

DEVELOPMENT OF PLATFORM INJECTION DEVICES ADDRESSING HUMAN FACTORS AT AN EARLY STAGE FOR DIFFERENT USER GROUPS

KAPITALMARKNADSDAG 20 SEPTEMBER Thomas Axelsson, CEO

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

ph Meters Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

One intelligent solution

Graft Delivery Devices

SMARTPILOT FOR YPSOMATE: TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE

SMART Communities Need A SMART Workforce Partners in SMART Education and Workforce Development & Training

Visceral Pain Market Share, Size, Analysis, Growth, Industry Trends and Forecasts to 2024 Hexa Research

POINT OF CARE DIAGNOSTICS

Boehringer Ingelheim Biopharmaceuticals in China. Your Reliable Contract Manufacturing Solution Provider

Partnering for Growth

PARTNERSHIP & SPONSORSHIP OPPORTUNITIES

If you inject diabetes medication, you should know how important correct injection technique is for effectively managing your diabetes.

New Horizons for Vaccine R&D&I in Europe

BD UnijectTM Auto-disable Prefillable Injection System Bridging the Gap

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

Improving Access to Healthcare in the Developing World. Renuka Gadde VP, Global Health 21 October 2012

Innovation in accessibility. How UniEvangélica promoted the inclusion of 22 employees who are deaf or hard of hearing within its hearing community

Guidewires Market Analysis, Size, Share, Growth, Industry Trends and Forecast to Hexa Research

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

Injection technique for different needle lengths

DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014

Medical Morphine Market Size, Share, Growth, Analysis, Trends, and Forescast to 2024 Hexa Research

Global Continuous Positive Airway Pressure(CPAP) Devices Market Research Report - Forecast to 2027

eclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

Bayer and Regeneron start additional Phase 3 Study for VEGF Trap-Eye in Wet Age-related Macular Degeneration

William Demant. Jefferies Healthcare Conf. Nov Søren B. Andersson, VP Investor Relations

Controlling Risk in your Supply Chain - Instruments of Change

概美科技. GuideMia Technologies, LLC Sept

ShoreTel Network Services Portfolio FAQ

Harm de Wildt MD TNI

IMPROVING PATIENT EXPERIENCE WITH PREFILLED SYRINGES AND NEW ONBOARDING TECHNIQUES

Table of Contents. 1. About Solvay Solvay at a Glance Group Portfolio Transforming Solvay Solvay s Portfolio Upgrade 7

Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( )

GLOBAL BIOANALYSIS CONSORTIUM

Future of Diabetes Research in Europe JDRF Perspective

The WHO END-TB Strategy

Global Invisible Braces Market: Trends, Opportunities and Forecasts ( )

Global Pediatric Development: We Are Making Progress. PMDA Perspective. Junko Sato, PhD PMDA

Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic

o Dental Implants Market By Material, Type, Structure Global Forecast To 2022 Report ID: MRDH Publishing Date: July, 2017

Michael L. Levitz Chief Financial Officer. November 15, 2017 Investor Presentation

Retina International General Assembly Auckland, New Zealand

EHR Developer Code of Conduct Frequently Asked Questions

Country Coverage. Company Coverage

The Dual Hormonal Artificial Pancreas in Diabetes Management. Medical Innovation Day Challenge

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

THE CHANGING PARADIGM EHS Information Driven Performance

Nutraceutical Packaging 2017 to 2021

FRANKFURT SITE TOUR 2017

Developing & Commercializing Targeted Small Molecule Drugs in Cancer

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

Preserving sites and protecting veins

BUILDING BUSINESS THROUGH SYNERGY

Vascular Endothelial Growth Factor Inhibitor Market

Vision. Mission. Hopelink s Values. Introduction. A community free of poverty

The more question you ask the more different answers you will get

Several internal issues and external causes resulted in our challenge to satisfactorily meet those time frames:

EMERGING MARKETS. Thomas Pollatz Marketing Manager Varian Brachytherapy. Gynecologic Cancer InterGroup Cervix Cancer Research Network

Joint Programming Initiative on Neurodegenerative Diseases. Prof. Philippe Amouyel Chair, JPND Management Board

For personal use only

Corporate Presentation

sports nutrition seminar

Improving access to medicines for patients in lower-income countries

OraSure Technologies. JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE June 4, 2014

GLOBAL NEUROSTIMULATION MARKET

User Manual Important: First read the Medication Guide that comes inside your FORTEO carton.

Economic Value Lab Efficiencies Safety Clinical Outcomes. Visit BD Booth AACC/ASCLS 2009 Annual Meeting

Healthcare in Qatar: National Health Strategy & National Diabetes Strategy

UNMC Nebraska Medicine Strategic Plan

ABAS Atlas-based Autosegmentation

Early defibrillation programs for the workplace. Give your workplace the power to save a life

Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( )

International Bureau for Epilepsy MEMBERSHIP GUIDE Benefits and Responsibilities

Radiation Oncology. The conf ident path to treatment Philips Radiation Oncology Solutions

ISO 13485:2016 MEDICAL DEVICES QMS TRANSITION GUIDE

EU support to hepatitis research. Anna Lönnroth Sjödén Health Research DG Research - European Commission

Positive Media Messages on Health and Diet for Parents and Children

Genomic Health. Kim Popovits, Chairman, CEO and President

CLARITY, PURE & bk3500 SIMPLE

The Danish Medicines Agency s availability strategy

Towards tailored and targeted asthma self-management using mobile technologies

Report ID: MRBT Publishing Date: July, 2017

Industrial careers. Palle Høy Jakobsen Director Head, R&D Academic Fellowships Novo Nordisk A/S

Oligonucleotide Testing Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 Hexa Research

Transcription:

Managing & Aligning Lists of Chemicals of High Concern Ivan Welvaert Director, Global Product Stewardship Office of Global Sustainability December, 2017 Boston, US 2017 BD. BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company. 1

Who is BD? We are a Fortune 500 company that is: Reaching the corners of the world: Locations in more than 50 countries with more than 40,000 associates worldwide Focused on improving efficiency of healthcare delivery and patient outcomes: We understand and serve the needs of our customers, including healthcare institutions, life science researchers, clinical laboratories, pharmaceutical and biotech partners and patients Part of the fabric of the healthcare industry since 1897: Alegacy of medical supplies and services, devices, laboratory equipment and diagnostic technologies Continually innovating practices across the healthcare continuum: Advancing cellular research capabilities and therapies, point-of-care diagnostics, medication management, infection prevention and patient safety 2

Global operations BD in Canada 700 associates BD in Western Europe 8,300 associates BD in United States 17,700 associates BD in Asia Pacific 6,500 associates BD in Latin America 9,800 associates BD in EMA 400 associates

BD Medical BD Nano Pen Needles Medication and Procedural Solutions Medication Management Solutions Diabetes Care Pharmaceutical Systems BD Physioject BD Insulin Syringe with the BD Ultra-Fine 6mm needle Pyxis MedStation ES System BD Emerald Alaris System ChloraPrep BD Nexiva 4

BD Life Sciences Segment Preanalytical Systems Diagnostic Systems Biosciences BD Vacutainer Blood Collection Tubes BD Kiestra Laboratory Automation BD Veritor BD FACSPresto BD Accuri BD MAX BD FACSAria Fusion BD Viper LT BD LSRFortessa X-20 5

Our approach to sustainability BD's sustainability strategy addresses the wide range of challenges in our industry, while helping to make a difference on relevant issues that affect society and the planet In addition to an ongoing focus on improving environmental performance, our sustainability strategy takes a broader view of BD s role in addressing global societal issues The 2020 Sustainability goals are spread across four pillars 6

Regulatory requirements Increasing requirements on reporting/labelling of products containing materials of concern (EU MDR - 2020) REACH registration 2018 deadline and revised Article SVHC reporting RoHS Phthalates 2019 deadline Growing number of restricted substance lists driven by: Global institutions National regulators Customers groups Environmental NGO s EPP programs 7

Managing in a dynamic environment Internal: Growing portfolio of more diverse products Global infrastructure with different customer bases across segments Cross functional end to end processes Various IT platforms External: Growing number of environmental regulations such as REACH, RoHS, CM, CA Prop65, GHS, etc. across the globe with local variations Chemicals list are dynamic (REACH, CLP, Ca Prop 65) Minimal standardisation across regions Multi-tier supplier networks (down stream users) including SME companies Supply chain communication: many requests for information in different formats, chemicals lists, thresholds. 8

Our focus Establishing a more formal chemicals management strategy, with standard process and systems Harmonizing substance supply base compliance processes and governance model Rolling out a scalable and integrated supplier collaboration platform Checking reported chemicals automatically against restricted substance lists Integrating Product Stewardship requirements in product development systems Integrating material risk into the supplier risk model 9

Long-term vision Overall goal: a product enters the market with a set of standardised product information to respond to ALL relevant product stewardship data requirements. How will we get there? Work with stakeholder groups to establish sustainable models for chemical data exchange, with common standards and platforms Explore developing technologies to capture chemical data across the supply chain (from cradle to grave and beyond) Minimize data collection and management efforts 10